Global and United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Insights, Forecast to 2026

Global and United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction
1.2 Market Segments
1.3 Key NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size Growth Rate by Type
1.4.2 Serum biomarkers
1.4.3 Hepatic fibrosis biomarkers
1.4.4 Apoptosis biomarkers
1.4.5 Oxidative stress biomarkers
1.4.6 Others
1.5 Market by Application
1.5.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size Growth Rate by Application
1.5.2 Pharma & CRO Industry
1.5.3 Hospitals
1.5.4 Diagnostic Labs
1.5.5 Academic Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size, Estimates and Forecasts
2.1.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue 2015-2026
2.1.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales 2015-2026
2.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 NASH (Non-alcoholic Steatohepatitis) Biomarkers Historical Market Size by Region (2015-2020)
2.3.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Estimates and Projections by Region (2021-2026)
2.4.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Region (2021-2026)
2.4.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Forecast by Region (2021-2026)
3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Competitor Landscape by Players
3.1 Global Top NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Manufacturers
3.1.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Manufacturers (2015-2020)
3.1.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Manufacturers (2015-2020)
3.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturers by Revenue
3.2.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Manufacturers (2015-2020)
3.2.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Share by Manufacturers (2015-2020)
3.2.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue in 2019
3.2.5 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Price by Manufacturers
3.4 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturing Base Distribution, Product Types
3.4.1 NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Type
3.4.3 Date of International Manufacturers Enter into NASH (Non-alcoholic Steatohepatitis) Biomarkers Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size by Type (2015-2020)
4.1.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Type (2015-2020)
4.1.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Type (2015-2020)
4.1.3 NASH (Non-alcoholic Steatohepatitis) Biomarkers Average Selling Price (ASP) by Type (2015-2026)
4.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size Forecast by Type (2021-2026)
4.2.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Type (2021-2026)
4.2.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Forecast by Type (2021-2026)
4.2.3 NASH (Non-alcoholic Steatohepatitis) Biomarkers Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size by Application (2015-2020)
5.1.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Application (2015-2020)
5.1.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Application (2015-2020)
5.1.3 NASH (Non-alcoholic Steatohepatitis) Biomarkers Price by Application (2015-2020)
5.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size Forecast by Application (2021-2026)
5.2.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Application (2021-2026)
5.2.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Forecast by Application (2021-2026)
5.2.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size YoY Growth 2015-2026
6.1.1 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales YoY Growth 2015-2026
6.1.2 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue YoY Growth 2015-2026
6.1.3 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Share in Global Market 2015-2026
6.2 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size by Players (International and Local Players)
6.2.1 United States Top NASH (Non-alcoholic Steatohepatitis) Biomarkers Players by Sales (2015-2020)
6.2.2 United States Top NASH (Non-alcoholic Steatohepatitis) Biomarkers Players by Revenue (2015-2020)
6.3 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Historic Market Review by Type (2015-2020)
6.3.1 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Type (2015-2020)
6.3.2 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Type (2015-2020)
6.3.3 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Price by Type (2015-2020)
6.4 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Type (2021-2026)
6.4.2 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Forecast by Type (2021-2026)
6.4.3 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Price Forecast by Type (2021-2026)
6.5 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Historic Market Review by Application (2015-2020)
6.5.1 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Application (2015-2020)
6.5.2 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Application (2015-2020)
6.5.3 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Price by Application (2015-2020)
6.6 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Application (2021-2026)
6.6.2 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Forecast by Application (2021-2026)
6.6.3 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Price Forecast by Application (2021-2026)
7 North America
7.1 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size YoY Growth 2015-2026
7.2 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Facts & Figures by Country
7.2.1 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country (2015-2020)
7.2.2 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size YoY Growth 2015-2026
8.2 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Facts & Figures by Country
8.2.1 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country
8.2.2 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size YoY Growth 2015-2026
9.2 Asia Pacific NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Facts & Figures by Country
9.2.1 Asia Pacific NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Region (2015-2020)
9.2.2 Asia Pacific NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size YoY Growth 2015-2026
10.2 Latin America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Facts & Figures by Country
10.2.1 Latin America NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country
10.2.2 Latin America NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size YoY Growth 2015-2026
11.2 Middle East and Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Facts & Figures by Country
11.2.1 Middle East and Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country
11.2.2 Middle East and Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 GENFIT SA
12.1.1 GENFIT SA Corporation Information
12.1.2 GENFIT SA Description and Business Overview
12.1.3 GENFIT SA Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Products Offered
12.1.5 GENFIT SA Recent Development
12.2 Gilead Sciences, Inc. (GILD)
12.2.1 Gilead Sciences, Inc. (GILD) Corporation Information
12.2.2 Gilead Sciences, Inc. (GILD) Description and Business Overview
12.2.3 Gilead Sciences, Inc. (GILD) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Products Offered
12.2.5 Gilead Sciences, Inc. (GILD) Recent Development
12.3 AstraZeneca
12.3.1 AstraZeneca Corporation Information
12.3.2 AstraZeneca Description and Business Overview
12.3.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
12.3.4 AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Products Offered
12.3.5 AstraZeneca Recent Development
12.4 Novartis AG
12.4.1 Novartis AG Corporation Information
12.4.2 Novartis AG Description and Business Overview
12.4.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Products Offered
12.4.5 Novartis AG Recent Development
12.5 Bristol-Myers Squibb Company
12.5.1 Bristol-Myers Squibb Company Corporation Information
12.5.2 Bristol-Myers Squibb Company Description and Business Overview
12.5.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Products Offered
12.5.5 Bristol-Myers Squibb Company Recent Development
12.6 Allergan Plc
12.6.1 Allergan Plc Corporation Information
12.6.2 Allergan Plc Description and Business Overview
12.6.3 Allergan Plc Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Products Offered
12.6.5 Allergan Plc Recent Development
12.7 Novo Nordisk A/S
12.7.1 Novo Nordisk A/S Corporation Information
12.7.2 Novo Nordisk A/S Description and Business Overview
12.7.3 Novo Nordisk A/S Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Products Offered
12.7.5 Novo Nordisk A/S Recent Development
12.8 Boehringer Ingelheim
12.8.1 Boehringer Ingelheim Corporation Information
12.8.2 Boehringer Ingelheim Description and Business Overview
12.8.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Products Offered
12.8.5 Boehringer Ingelheim Recent Development
12.9 Pfizer Inc
12.9.1 Pfizer Inc Corporation Information
12.9.2 Pfizer Inc Description and Business Overview
12.9.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Products Offered
12.9.5 Pfizer Inc Recent Development
12.11 GENFIT SA
12.11.1 GENFIT SA Corporation Information
12.11.2 GENFIT SA Description and Business Overview
12.11.3 GENFIT SA Sales, Revenue and Gross Margin (2015-2020)
12.11.4 GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Products Offered
12.11.5 GENFIT SA Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key NASH (Non-alcoholic Steatohepatitis) Biomarkers Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Segments
Table 2. Ranking of Global Top NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Serum biomarkers
Table 5. Major Manufacturers of Hepatic fibrosis biomarkers
Table 6. Major Manufacturers of Apoptosis biomarkers
Table 7. Major Manufacturers of Oxidative stress biomarkers
Table 8. Major Manufacturers of Others
Table 9. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size Growth Rate by Application 2020-2026 (K Units)
Table 10. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 11. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Regions 2015-2020 (K Units)
Table 12. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Regions (2015-2020)
Table 13. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Region (2021-2026) (K Units)
Table 15. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Manufacturers (2015-2020) (K Units)
Table 16. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Share by Manufacturers (2015-2020)
Table 17. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NASH (Non-alcoholic Steatohepatitis) Biomarkers as of 2019)
Table 19. NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers NASH (Non-alcoholic Steatohepatitis) Biomarkers Price (2015-2020) (USD/Unit)
Table 22. NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Type
Table 24. Date of International Manufacturers Enter into NASH (Non-alcoholic Steatohepatitis) Biomarkers Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Type (2015-2020) (K Units)
Table 27. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Share by Type (2015-2020)
Table 28. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Type (2015-2020) (US$ Million)
Table 29. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Share by Type (2015-2020)
Table 30. NASH (Non-alcoholic Steatohepatitis) Biomarkers Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 31. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Share by Type (2021-2026)
Table 32. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Application (2015-2020) (K Units)
Table 33. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Share by Application (2015-2020)
Table 34. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Share by Application (2021-2026)
Table 35. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share Forecast by Application (2021-2026)
Table 36. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Application (2015-2020) (US$ Million)
Table 37. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share Forecast by Application (2021-2026)
Table 38. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units) of Key Companies (2015-2020)
Table 39. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Share by Company (2015-2020)
Table 40. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue (US$ Million) by Company (2015-2020)
Table 41. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units) by Type (2015-2020)
Table 42. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Share by Type (2015-2020)
Table 43. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue (US$ Million) Market Share by Type (2015-2020)
Table 44. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Price (K Units) by Type (2015-2020)
Table 45. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units) by Type (2021-2026)
Table 46. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Share by Type (2021-2026)
Table 47. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue (US$ Million) Market Share by Type (2021-2026)
Table 48. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Share by Type (2021-2026)
Table 49. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Price (K Units) by Type (2021-2026)
Table 50. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units) by Application (2015-2020)
Table 51. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Share by Application (2015-2020)
Table 52. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue (US$ Million) Market Share by Application (2015-2020)
Table 53. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units) by Application (2021-2026)
Table 54. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Share by Application (2021-2026)
Table 55. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue (US$ Million) Market Share by Application (2021-2026)
Table 56. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Share by Application (2021-2026)
Table 57. North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country (2015-2020) (K Units)
Table 58. North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Country (2015-2020)
Table 59. North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Country (2015-2020) (US$ Million)
Table 60. North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Country (2015-2020)
Table 61. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country (2015-2020) (K Units)
Table 62. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Country (2015-2020)
Table 63. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Country (2015-2020) (US$ Million)
Table 64. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Country (2015-2020)
Table 65. Asia Pacific NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Region (2015-2020) (K Units)
Table 66. Asia Pacific NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Region (2015-2020)
Table 67. Asia Pacific NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Region (2015-2020) (US$ Million)
Table 68. Asia Pacific NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Region (2015-2020)
Table 69. Latin America NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country (2015-2020) (K Units)
Table 70. Latin America NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Country (2015-2020)
Table 71. Latin Americaa NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Country (2015-2020) (US$ Million)
Table 72. Latin America NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country (2015-2020) (K Units)
Table 74. Middle East and Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Country (2015-2020)
Table 75. Middle East and Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Country (2015-2020) (US$ Million)
Table 76. Middle East and Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Country (2015-2020)
Table 77. GENFIT SA Corporation Information
Table 78. GENFIT SA Description and Business Overview
Table 79. GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Product
Table 81. GENFIT SA Recent Development
Table 82. Gilead Sciences, Inc. (GILD) Corporation Information
Table 83. Gilead Sciences, Inc. (GILD) Description and Business Overview
Table 84. Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. Gilead Sciences, Inc. (GILD) Product
Table 86. Gilead Sciences, Inc. (GILD) Recent Development
Table 87. AstraZeneca Corporation Information
Table 88. AstraZeneca Description and Business Overview
Table 89. AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 90. AstraZeneca Product
Table 91. AstraZeneca Recent Development
Table 92. Novartis AG Corporation Information
Table 93. Novartis AG Description and Business Overview
Table 94. Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 95. Novartis AG Product
Table 96. Novartis AG Recent Development
Table 97. Bristol-Myers Squibb Company Corporation Information
Table 98. Bristol-Myers Squibb Company Description and Business Overview
Table 99. Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. Bristol-Myers Squibb Company Product
Table 101. Bristol-Myers Squibb Company Recent Development
Table 102. Allergan Plc Corporation Information
Table 103. Allergan Plc Description and Business Overview
Table 104. Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 105. Allergan Plc Product
Table 106. Allergan Plc Recent Development
Table 107. Novo Nordisk A/S Corporation Information
Table 108. Novo Nordisk A/S Description and Business Overview
Table 109. Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 110. Novo Nordisk A/S Product
Table 111. Novo Nordisk A/S Recent Development
Table 112. Boehringer Ingelheim Corporation Information
Table 113. Boehringer Ingelheim Description and Business Overview
Table 114. Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 115. Boehringer Ingelheim Product
Table 116. Boehringer Ingelheim Recent Development
Table 117. Pfizer Inc Corporation Information
Table 118. Pfizer Inc Description and Business Overview
Table 119. Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 120. Pfizer Inc Product
Table 121. Pfizer Inc Recent Development
Table 122. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 123. Key Challenges
Table 124. Market Risks
Table 125. Main Points Interviewed from Key NASH (Non-alcoholic Steatohepatitis) Biomarkers Players
Table 126. NASH (Non-alcoholic Steatohepatitis) Biomarkers Customers List
Table 127. NASH (Non-alcoholic Steatohepatitis) Biomarkers Distributors List
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Picture
Figure 2. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Type in 2020 & 2026
Figure 3. Serum biomarkers Product Picture
Figure 4. Hepatic fibrosis biomarkers Product Picture
Figure 5. Apoptosis biomarkers Product Picture
Figure 6. Oxidative stress biomarkers Product Picture
Figure 7. Others Product Picture
Figure 8. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Application in 2020 & 2026
Figure 9. Pharma & CRO Industry
Figure 10. Hospitals
Figure 11. Diagnostic Labs
Figure 12. Academic Research Institutes
Figure 13. NASH (Non-alcoholic Steatohepatitis) Biomarkers Report Years Considered
Figure 14. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size 2015-2026 (US$ Million)
Figure 15. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales 2015-2026 (K Units)
Figure 16. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Region (2015-2020)
Figure 18. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Region in 2019
Figure 19. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Region (2015-2020)
Figure 20. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Region in 2019
Figure 21. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue in 2019
Figure 23. NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Type (2015-2020)
Figure 25. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Type in 2019
Figure 26. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Type (2015-2020)
Figure 27. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Type in 2019
Figure 28. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Share by Price Range (2015-2020)
Figure 29. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Application (2015-2020)
Figure 30. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Application in 2019
Figure 31. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Application (2015-2020)
Figure 32. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Application in 2019
Figure 33. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Growth Rate 2015-2026 (K Units)
Figure 34. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate 2015-2026 (US$ Million)
Figure 35. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Share in Global Market 2015-2026
Figure 36. United States 5 and 10 Largest NASH (Non-alcoholic Steatohepatitis) Biomarkers Players Market Share by Revenue in NASH (Non-alcoholic Steatohepatitis) Biomarkers in 2019
Figure 37. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Share by Type (2015-2020)
Figure 38. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate by Type in 2015 & 2019
Figure 39. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Share by Application (2015-2020)
Figure 40. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate by Application in 2015 & 2019
Figure 41. North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Growth Rate 2015-2020 (K Units)
Figure 42. North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Country in 2019
Figure 44. North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Country in 2019
Figure 45. U.S. NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 46. U.S. NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Canada NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 48. Canada NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Growth Rate 2015-2020 (K Units)
Figure 50. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate 2015-2020 (US$ Million)
Figure 51. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Country in 2019
Figure 52. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Country in 2019
Figure 53. Germany NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 54. Germany NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. France NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Growth Rate (2015-2020) (K Units)
Figure 56. France NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. U.K. NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Growth Rate (2015-2020) (K

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs